Which has higher valuation and earnings, PEN or LNTH?

Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.45B 8.62 $177.69M $4.34 73.41 Lantheus $1.54B 4.45 $233.56M $4.15 25.40

Is PEN or LNTH more profitable?

Lantheus has a net margin of 18.05% compared to Penumbra's net margin of 11.76%. Lantheus' return on equity of 29.32% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 11.76% 10.87% 8.45% Lantheus 18.05% 29.32% 15.00%

Does the media refer more to PEN or LNTH?

In the previous week, Lantheus had 1 more articles in the media than Penumbra. MarketBeat recorded 4 mentions for Lantheus and 3 mentions for Penumbra. Lantheus' average media sentiment score of 1.19 beat Penumbra's score of 0.00 indicating that Lantheus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lantheus 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, ITGR or PEN?

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 1.77 $102.81M $4.01 24.04 Penumbra $1.45B 8.62 $177.69M $4.34 73.41

Is ITGR or PEN more profitable?

Penumbra has a net margin of 11.76% compared to Integer's net margin of 7.64%. Integer's return on equity of 12.83% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Integer 7.64% 12.83% 6.51% Penumbra 11.76% 10.87% 8.45%

Does the media refer more to ITGR or PEN?

In the previous week, Penumbra had 1 more articles in the media than Integer. MarketBeat recorded 3 mentions for Penumbra and 2 mentions for Integer. Integer's average media sentiment score of 0.84 beat Penumbra's score of 0.00 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer GEHC or PEN?

In the previous week, GE HealthCare Technologies had 9 more articles in the media than Penumbra. MarketBeat recorded 12 mentions for GE HealthCare Technologies and 3 mentions for Penumbra. GE HealthCare Technologies' average media sentiment score of 0.78 beat Penumbra's score of 0.00 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 3 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PHG or PEN?

Penumbra has a consensus price target of $360.33, indicating a potential upside of 13.09%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Penumbra 1 Sell rating(s) 14 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.11

Does the media favor PHG or PEN?

In the previous week, Penumbra had 1 more articles in the media than Koninklijke Philips. MarketBeat recorded 3 mentions for Penumbra and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 0.00 equaled Penumbra'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation and earnings, ZBH or PEN?

Zimmer Biomet has higher revenue and earnings than Penumbra. Zimmer Biomet is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zimmer Biomet $8.23B 2.21 $705.20M $3.85 24.44 Penumbra $1.45B 8.62 $177.69M $4.34 73.41

Is ZBH or PEN more profitable?

Penumbra has a net margin of 11.76% compared to Zimmer Biomet's net margin of 9.05%. Zimmer Biomet's return on equity of 13.24% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Zimmer Biomet 9.05% 13.24% 7.28% Penumbra 11.76% 10.87% 8.45%

Does the media favor ZBH or PEN?

In the previous week, Zimmer Biomet had 8 more articles in the media than Penumbra. MarketBeat recorded 11 mentions for Zimmer Biomet and 3 mentions for Penumbra. Zimmer Biomet's average media sentiment score of 1.16 beat Penumbra's score of 0.00 indicating that Zimmer Biomet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Penumbra (PEN) Competitors

$318.61 +0.51 (+0.16%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$317.72 -0.89 (-0.28%)

As of 07/13/2026 06:18 PM Eastern

Compare

PEN vs. LNTH, ITGR, GEHC, PHG, and ZBH

Should you buy Penumbra stock or one of its competitors? MarketBeat compares Penumbra with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Penumbra include Lantheus (LNTH), Integer (ITGR), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), and Zimmer Biomet (ZBH). These companies are all part of the "medical" sector.

How does Penumbra compare to Lantheus?

Penumbra (NYSE:PEN) and Lantheus (NASDAQ:LNTH) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

In the previous week, Lantheus had 1 more articles in the media than Penumbra. MarketBeat recorded 4 mentions for Lantheus and 3 mentions for Penumbra. Lantheus' average media sentiment score of 1.19 beat Penumbra's score of 0.00 indicating that Lantheus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lantheus	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.45B	8.62	$177.69M	$4.34	73.41
Lantheus	$1.54B	4.45	$233.56M	$4.15	25.40

Lantheus has a net margin of 18.05% compared to Penumbra's net margin of 11.76%. Lantheus' return on equity of 29.32% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
Lantheus	18.05%	29.32%	15.00%

Penumbra presently has a consensus price target of $360.33, indicating a potential upside of 13.09%. Lantheus has a consensus price target of $108.29, indicating a potential upside of 2.75%. Given Penumbra's higher probable upside, equities research analysts clearly believe Penumbra is more favorable than Lantheus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	1 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.11
Lantheus	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Penumbra has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market. Comparatively, Lantheus has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market.

88.9% of Penumbra shares are held by institutional investors. Comparatively, 99.1% of Lantheus shares are held by institutional investors. 2.9% of Penumbra shares are held by company insiders. Comparatively, 1.7% of Lantheus shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Lantheus beats Penumbra on 10 of the 16 factors compared between the two stocks.

How does Penumbra compare to Integer?

Integer (NYSE:ITGR) and Penumbra (NYSE:PEN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Penumbra has a net margin of 11.76% compared to Integer's net margin of 7.64%. Integer's return on equity of 12.83% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Penumbra	11.76%	10.87%	8.45%

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	1.77	$102.81M	$4.01	24.04
Penumbra	$1.45B	8.62	$177.69M	$4.34	73.41

In the previous week, Penumbra had 1 more articles in the media than Integer. MarketBeat recorded 3 mentions for Penumbra and 2 mentions for Integer. Integer's average media sentiment score of 0.84 beat Penumbra's score of 0.00 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

99.3% of Integer shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 2.9% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Integer has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Integer presently has a consensus target price of $99.29, suggesting a potential upside of 2.99%. Penumbra has a consensus target price of $360.33, suggesting a potential upside of 13.09%. Given Penumbra's higher possible upside, analysts clearly believe Penumbra is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
Penumbra	1 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.11

Summary

Penumbra beats Integer on 10 of the 16 factors compared between the two stocks.

How does Penumbra compare to GE HealthCare Technologies?

GE HealthCare Technologies (NASDAQ:GEHC) and Penumbra (NYSE:PEN) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 2.9% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

GE HealthCare Technologies has higher revenue and earnings than Penumbra. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$20.63B	1.44	$2.08B	$4.18	15.62
Penumbra	$1.45B	8.62	$177.69M	$4.34	73.41

GE HealthCare Technologies presently has a consensus target price of $79.48, indicating a potential upside of 21.69%. Penumbra has a consensus target price of $360.33, indicating a potential upside of 13.09%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe GE HealthCare Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	10 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.50
Penumbra	1 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.11

Penumbra has a net margin of 11.76% compared to GE HealthCare Technologies' net margin of 9.10%. GE HealthCare Technologies' return on equity of 20.46% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.10%	20.46%	5.73%
Penumbra	11.76%	10.87%	8.45%

In the previous week, GE HealthCare Technologies had 9 more articles in the media than Penumbra. MarketBeat recorded 12 mentions for GE HealthCare Technologies and 3 mentions for Penumbra. GE HealthCare Technologies' average media sentiment score of 0.78 beat Penumbra's score of 0.00 indicating that GE HealthCare Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	3 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

GE HealthCare Technologies has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market.

Summary

GE HealthCare Technologies beats Penumbra on 9 of the 16 factors compared between the two stocks.

How does Penumbra compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and Penumbra (NYSE:PEN) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

Penumbra has a net margin of 11.76% compared to Koninklijke Philips' net margin of 5.49%. Koninklijke Philips' return on equity of 13.51% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	5.49%	13.51%	5.48%
Penumbra	11.76%	10.87%	8.45%

In the previous week, Penumbra had 1 more articles in the media than Koninklijke Philips. MarketBeat recorded 3 mentions for Penumbra and 2 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 0.00 equaled Penumbra'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Penumbra has a consensus price target of $360.33, indicating a potential upside of 13.09%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Penumbra	1 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.11

Koninklijke Philips has a beta of 0.75, suggesting that its share price is 25% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, suggesting that its share price is 30% less volatile than the broader market.

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Koninklijke Philips has higher revenue and earnings than Penumbra. Koninklijke Philips is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.33	$1.01B	$1.17	23.36
Penumbra	$1.45B	8.62	$177.69M	$4.34	73.41

Summary

Penumbra beats Koninklijke Philips on 11 of the 15 factors compared between the two stocks.

How does Penumbra compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and Penumbra (NYSE:PEN) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

In the previous week, Zimmer Biomet had 8 more articles in the media than Penumbra. MarketBeat recorded 11 mentions for Zimmer Biomet and 3 mentions for Penumbra. Zimmer Biomet's average media sentiment score of 1.16 beat Penumbra's score of 0.00 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zimmer Biomet has a beta of 0.46, meaning that its share price is 54% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market.

Zimmer Biomet has higher revenue and earnings than Penumbra. Zimmer Biomet is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	2.21	$705.20M	$3.85	24.44
Penumbra	$1.45B	8.62	$177.69M	$4.34	73.41

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 1.3% of Zimmer Biomet shares are owned by insiders. Comparatively, 2.9% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Zimmer Biomet presently has a consensus target price of $102.33, indicating a potential upside of 8.76%. Penumbra has a consensus target price of $360.33, indicating a potential upside of 13.09%. Given Penumbra's higher probable upside, analysts plainly believe Penumbra is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3 Sell rating(s)	13 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.25
Penumbra	1 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.11

Penumbra has a net margin of 11.76% compared to Zimmer Biomet's net margin of 9.05%. Zimmer Biomet's return on equity of 13.24% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.05%	13.24%	7.28%
Penumbra	11.76%	10.87%	8.45%

Summary

Zimmer Biomet beats Penumbra on 9 of the 17 factors compared between the two stocks.

Get Penumbra News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PEN vs. The Competition

Export

Metric	Penumbra	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$12.51B	$7.63B	$7.05B	$23.46B
Dividend Yield	N/A	1.32%	2.68%	4.02%
P/E Ratio	73.41	50.28	27.11	31.08
Price / Sales	8.62	76.45	587.92	19.77
Price / Cash	74.00	26.85	29.22	18.64
Price / Book	8.74	7.32	10.75	4.77
Net Income	$177.69M	$162.30M	$3.58B	$1.06B
7 Day Performance	0.07%	-0.99%	-2.06%	-0.23%
1 Month Performance	-0.01%	0.19%	3.32%	-0.11%
1 Year Performance	33.41%	4.08%	26.35%	16.46%

Penumbra Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PEN Penumbra	1.6173 of 5 stars	$318.61 +0.2%	$360.33 +13.1%	+34.2%	$12.51B	$1.45B	73.41	4,700
LNTH Lantheus	3.0926 of 5 stars	$102.82 -6.4%	$101.86 -0.9%	+29.6%	$7.15B	$1.54B	24.78	1,193	Positive News
ITGR Integer	1.9942 of 5 stars	$93.36 -1.9%	$98.71 +5.7%	-19.5%	$3.23B	$1.85B	23.28	11,000
GEHC GE HealthCare Technologies	4.9399 of 5 stars	$64.84 -1.1%	$80.20 +23.7%	-13.1%	$29.82B	$20.63B	15.51	54,000	Analyst Forecast
PHG Koninklijke Philips	1.87 of 5 stars	$28.17 +1.6%	N/A	+13.8%	$27.27B	$20.17B	24.14	65,340

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PEN) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Penumbra (PEN) Competitors

PEN vs. LNTH, ITGR, GEHC, PHG, and ZBH

How does Penumbra compare to Lantheus?

Summary

How does Penumbra compare to Integer?

Summary

How does Penumbra compare to GE HealthCare Technologies?

Summary

How does Penumbra compare to Koninklijke Philips?

Summary

How does Penumbra compare to Zimmer Biomet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PEN vs. The Competition

Penumbra Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Penumbra (PEN) Competitors

PEN vs. LNTH, ITGR, GEHC, PHG, and ZBH

How does Penumbra compare to Lantheus?

Does the media refer more to PEN or LNTH?

Which has higher valuation and earnings, PEN or LNTH?

Is PEN or LNTH more profitable?

Do analysts rate PEN or LNTH?

Which has more risk and volatility, PEN or LNTH?

Do insiders and institutionals hold more shares of PEN or LNTH?

Summary

How does Penumbra compare to Integer?

Is ITGR or PEN more profitable?

Which has preferable earnings and valuation, ITGR or PEN?

Does the media refer more to ITGR or PEN?

Do institutionals & insiders hold more shares of ITGR or PEN?

Which has more risk and volatility, ITGR or PEN?

Do analysts prefer ITGR or PEN?

Summary

How does Penumbra compare to GE HealthCare Technologies?

Do insiders and institutionals believe in GEHC or PEN?

Which has preferable valuation & earnings, GEHC or PEN?

Do analysts prefer GEHC or PEN?

Is GEHC or PEN more profitable?

Does the media prefer GEHC or PEN?

Which has more risk & volatility, GEHC or PEN?

Summary

How does Penumbra compare to Koninklijke Philips?

Is PHG or PEN more profitable?

Does the media favor PHG or PEN?

Do analysts prefer PHG or PEN?

Which has more risk and volatility, PHG or PEN?

Do insiders & institutionals believe in PHG or PEN?

Which has stronger earnings and valuation, PHG or PEN?

Summary

How does Penumbra compare to Zimmer Biomet?

Does the media favor ZBH or PEN?

Which has more volatility and risk, ZBH or PEN?

Which has better valuation and earnings, ZBH or PEN?

Do institutionals and insiders believe in ZBH or PEN?

Do analysts prefer ZBH or PEN?

Is ZBH or PEN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PEN vs. The Competition

Penumbra Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools